Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can tracking heart-kidney-metabolic syndrome in india reveal its hidden patterns?

NCT ID NCT07718789

Knowledge-focused Sponsor: Centre for Chronic Disease Control, India Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 22, 2026 · Last updated Jul 23, 2026 · Updated 1 time

Summary

This observational registry study follows 2,250 adults with cardiovascular-kidney-metabolic syndrome (CKMS) at five hospitals in India. Researchers aim to understand how the condition progresses over 12 months, how it affects quality of life, and what treatments doctors prescribe. Participants provide health information, blood and urine samples, and undergo heart tests, while continuing their usual medical care.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this registry could reveal how CKMS progresses in Indian adults and guide better prevention and treatment strategies.
What could go wrong
As an observational registry, it cannot test treatments or prove cause and effect. Results may not apply to other populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 2,250 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Jul 2026

An estimate. Start dates often move.

Expected to finish

Dec 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Adults receiving care at the outpatient departments of Cardiology and Internal Medicine at participating tertiary care hospitals in India who have Cardiovascular-Kidney-Metabolic Syndrome (CKMS) or CKMS-related risk factors and are managed under routine clinical practice. Eligible participants will be consecutively enrolled after providing written informed consent.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Adults ≥18 years visiting select tertiary care hospitals AND 2. Presenting with signs and/or symptoms of CKMS : 2.1. Adiposity i.e., Body Mass Index \> 23, and/or large waist circumference \[women: ≥ 80 cm; men: ≥ 90 cm\] AND/OR 2.2. Metabolic syndrome i.e., new or a known case of hypertension, type-2 diabetes, dyslipidaemia, chronic kidney disease, and/or PCOS. AND/OR 2.3. Presenting with signs of subclinical CVD and/or with a history of clinical CVD with metabolic syndrome AND 3. Willing and able to provide informed consent. Exclusion Criteria: 1. Stage 0 CKMS i.e., a healthy state characterized by normal body weight, absence of metabolic risk factors such as hypertension, type-2 diabetes, dyslipidemias, preserved kidney function with no evidence of CKD, and no subclinical or clinical manifestations of CVDs. 2. Neuro-cognitive, psychiatric, or any surgical conditions which prevents in obtaining reliable clinical data. 3. Any surgical and/or medical condition that is likely to prevent the participant from complying with the requirements of the study or completing the study. 4. Participants already taking part in another clinical trial. 5. Pregnant and/or lactating women.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cardiovascular-kidney-metabolic syndrome are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cardiovascular disorder cardiovascular-kidney-metabolic syndrome chronic renal failure syndrome hypertensive disorder hypertriglyceridemia Obesity type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cardiovascular-kidney-metabolic syndrome

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The official record

    The full official record for this study. This one lists no contact details, but it is the first place any would appear.

    Open the record ↗

  2. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

More trials for these conditions

Other studies related to the condition(s) this trial covers.